Atlas Trials

A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD

Clinical trial NCT00469352 · COMPLETED

Trial details

NCT number
NCT00469352
Sponsor
Oregon Health and Science University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Macular Degeneration
Start date
2007-05-01
Primary completion
2010-04-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.